The Company’s miR Sentinel™ Prostate Test is a new method to analyze small non-coding RNAs (sncRNA) derived from a simple, non-invasive urine specimen from age-eligible men.
Gallium 68 PSMA PET challenging certain guidelines?
An international research team has discovered a principle that explains the metastasizing of prostate cancer.
Findings demonstrate the value of apalutamide as a treatment option for nonmetastatic castration-resistant prostate cancer.
From Renal & Urology News, Prostate Cancer Advisor
From a report appearing on the US Department of Health and Human Services Effective Health Care page